- Home
- PCVX vs HTGC Comparison
PCVX vs HTGC Comparison
Compare PCVX & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- HTGC
- Stock Information
- Founded
- PCVX 2013
- HTGC 2003
- Country
- PCVX United States
- HTGC United States
- Employees
- PCVX N/A
- HTGC N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- HTGC Investment Managers
- Sector
- PCVX Health Care
- HTGC Finance
- Exchange
- PCVX Nasdaq
- HTGC Nasdaq
- Market Cap
- PCVX 4.0B
- HTGC 3.5B
- IPO Year
- PCVX 2020
- HTGC 2005
- Fundamental
- Price
- PCVX $41.85
- HTGC $17.87
- Analyst Decision
- PCVX Strong Buy
- HTGC Buy
- Analyst Count
- PCVX 8
- HTGC 8
- Target Price
- PCVX $114.17
- HTGC $21.13
- AVG Volume (30 Days)
- PCVX 1.6M
- HTGC 1.3M
- Earning Date
- PCVX 11-04-2025
- HTGC 10-30-2025
- Dividend Yield
- PCVX N/A
- HTGC 10.57%
- EPS Growth
- PCVX N/A
- HTGC N/A
- EPS
- PCVX N/A
- HTGC 1.75
- Revenue
- PCVX N/A
- HTGC $516,847,000.00
- Revenue This Year
- PCVX N/A
- HTGC $8.72
- Revenue Next Year
- PCVX N/A
- HTGC $9.57
- P/E Ratio
- PCVX N/A
- HTGC $10.15
- Revenue Growth
- PCVX N/A
- HTGC 4.54
- 52 Week Low
- PCVX $27.66
- HTGC $15.65
- 52 Week High
- PCVX $116.00
- HTGC $22.04
- Technical
- Relative Strength Index (RSI)
- PCVX 51.82
- HTGC 48.94
- Support Level
- PCVX $39.87
- HTGC $17.40
- Resistance Level
- PCVX $45.90
- HTGC $18.11
- Average True Range (ATR)
- PCVX 1.86
- HTGC 0.28
- MACD
- PCVX -0.62
- HTGC 0.10
- Stochastic Oscillator
- PCVX 33.36
- HTGC 72.22
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.